We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUROW
1901
CALL
Aurora Innovation Warrant
AUROW
$317M
$765K ﹤0.01%
550,000
SEDA.WS
1902
CALL
DELISTED
SDCL EDGE Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary share at an exercise price of $11.50
SEDA.WS
$762K ﹤0.01%
74,241
FBT icon
1903
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.84B
$760K ﹤0.01%
4,900
-4,500
-48% -$707K
KT icon
1904
KT
KT
$8.74B
$759K ﹤0.01%
+66,900
New +$856K
ASML icon
1905
ASML
ASML
$596B
$758K ﹤0.01%
1,114
+914
+457% +$587K
MODV
1906
DELISTED
ModivCare
MODV
$754K ﹤0.01%
8,972
-29,675
-77% -$2.85M
BEKE icon
1907
PUT
KE Holdings
BEKE
$17.7B
$754K ﹤0.01%
+40,000
New +$741K
XLU icon
1908
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$23.1B
$751K ﹤0.01%
22,200
+600
+3% +$20.3K
ITOS
1909
DELISTED
iTeos Therapeutics
ITOS
$749K ﹤0.01%
+55,009
New +$986K
XLP icon
1910
PUT
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$747K ﹤0.01%
+10,000
New +$731K
PPBI
1911
DELISTED
Pacific Premier Bancorp
PPBI
$747K ﹤0.01%
+31,099
New +$941K
WULF icon
1912
TeraWulf
WULF
$7.48B
$745K ﹤0.01%
792,389
CBT icon
1913
Cabot Corp
CBT
$4.72B
$742K ﹤0.01%
9,681
-57,671
-86% -$4.32M
ORIA
1914
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
$741K ﹤0.01%
72,475
-223,411
-76% -$2.27M
DHX icon
1915
DHI Group
DHX
$177M
$736K ﹤0.01%
+189,601
New +$900K
KLXE icon
1916
KLX Energy Services
KLXE
$43.1M
$733K ﹤0.01%
62,902
+27,263
+76% +$371K
HHR
1917
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$732K ﹤0.01%
416,181
ARI
1918
Apollo Commercial Real Estate
ARI
$864M
$732K ﹤0.01%
+78,612
New +$870K
EYE icon
1919
National Vision
EYE
$1.76B
$732K ﹤0.01%
+38,833
New +$1.26M
MD icon
1920
Pediatrix Medical
MD
$2.2B
$729K ﹤0.01%
48,917
+14,172
+41% +$215K
CLINW
1921
CALL
DELISTED
Clean Earth Acquisitions Corp. Warrant
CLINW
$728K ﹤0.01%
70,431
GASS icon
1922
StealthGas
GASS
$326M
$726K ﹤0.01%
278,312
-16,660
-6% -$46.1K
BELFB
1923
Bel Fuse Inc Class B
BELFB
$3.45B
$724K ﹤0.01%
+19,254
New +$693K
DMRC icon
1924
Digimarc Corp
DMRC
$143M
$719K ﹤0.01%
+36,607
New +$739K
HESM icon
1925
Hess Midstream
HESM
$5.19B
$718K ﹤0.01%
24,809
+7,954
+47% +$232K

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.